Publications by authors named "O Stuve"

Claim this Profile
L
Lipoic Acid for Treatment of Progressive Multiple Sclerosis: A Phase 2 Randomized Clinical Trial.
Rebecca I Spain, M Mateo Paz Soldán, Mark S Freedman, Pavle Repovic, Andrew J Solomon, Olaf Stuve

Neurology· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Remyelination therapies are achievable in clinical practice-No.
Afsaneh Shirani, Olaf Stuve

Mult Scler· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucagon‑like peptide‑1 receptor agonists in multiple sclerosis: therapeutic promise, challenges, and future directions.
Afsaneh Shirani, Olaf Stuve

Expert Opin Investig Drugs· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reporting patterns of multiple sclerosis with immune checkpoint inhibitors: analysis of the FDA Adverse Event Reporting System.
Afsaneh Shirani, Samuel A Goldlust, Olaf Stuve

Ther Adv Neurol Disord· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the association of disease-modifying therapies for multiple sclerosis and BTK inhibitors with epilepsy.
Afsaneh Shirani, Nil Saez-Calveras, Jack P Antel, Moein Yaqubi, Wayne Moore, Olaf Stuve

Ther Adv Neurol Disord· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis